showed clear H 2 O 2 (and OGD)-induced Nrf2-dependent gene activation, contrary to that reported in ref. 1. One possible explanation for this discrepancy lies in their Nrf2 assay: a luciferase reporter incorporating the ARE of the NQO1 promoter (1) . Different AREs can have different Nrf2 dependencies for basal and/or inducible activity, and we observe relatively weak Nqo1 induction by 100 μM H 2 O 2 (2.1-± 0.06-fold; n = 5). Basal Nrf2 activity seems sufficient for strong Nqo1 expression in astrocytes: basal Nqo1 expression in Nrf2 −/− cultures is only 14 ± 2% of that in WT. Another potential explanation is that H 2 O 2 doses >30 μM were not studied, because 100 μM were reportedly toxic based on 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay (1) . However, the MTT assay may overstate toxicity, because it measures cellular NAD (P)H-dependent reducing activity, which could drop if subtoxic stress causes NAD(P)H levels to fall. We see no evidence of H 2 O 2 toxicity in astrocytes up to 200 μM, as assessed by either ATP assay or nuclear integrity (Fig. 1) . In contrast to the reported Nrf2-independence of adaptive astrocytic neuroprotective responses acting on immature neurons (48 h in culture) (1), we find that astrocytic Nrf2 contributes to adaptive neuroprotective responses in more mature neurons (Fig. 2) . A brief, nonneurotoxic episode of OGD (90 min) applied to mixed cultures preconditions neurons against a subsequent neurotoxic OGD episode 24 h later (Fig. 2) . This preconditioning episode activates Nrf2 in mixed cultures (Srxn1: 1.97-± 0.06-fold; Hmox1: 1.48-± 0.08-fold; n = 6) but not in pure neuronal cultures, and Hmox1 induction is restricted to astrocytes. In Nrf2 −/− cultures, neuronal vulnerability to OGD was similar to Nrf2 +/+ cultures (Fig. 2) . However, the brief OGDinduced preconditioning effect was substantially lower in Nrf2 −/− cultures ( Fig. 2) , strongly implicating Nrf2 activation in ischemic preconditioning. This response may also be relevant in vivo: a standard preconditioning inducing stimulus in adult mice (15-min occlusion of the middle cerebral artery) triggered Nrf2-target gene induction in the ipsilateral cortical hemisphere (Fig. 2) . Finally, we observe that subtoxic H 2 O 2 also induces Hmox1/Srxn1 expression in human ES cell-derived astrocytes ( Fig. 2) , suggesting that human Nrf2 is activated by mild oxidative stress. Thus, in addition to Nrf2-independent pathways (1) or 5 μM tert-Butylhydroquinone (tBHQ) for 6 h or subjected to a 3-h episode of oxygen-glucose deprivation (OGD), after which they were returned to normoxia for an additional 3 h. Expression of Srxn1 and Hmox1 mRNA was analyzed by quantitative real-time PCR as described (3) ) were obtained by plating at low density in DMEM + 10% FBS. All cell types were used after 9-11 d in culture. For OGD, cells were placed in degassed medium containing mannitol instead of glucose and put in a modular incubator chamber flushed with 95% N 2 and 5% CO 2 according to manufacturer's instructions (Billups-Rothenberg, Del Mar, CA). *P < 0.05 Bonferonni t test (n = 4-8). (Inset) Concurrent immunofluorescent detection of Gfap and Hmox1 protein in mixed neuronal/astrocyte cultures treated as indicated for 24 h. Example pictures illustrate the localization of Hmox1 expression to GFAP+ astrocytes. GFAP monoclonal antibody clone GA5 (Sigma) and Hmox1 polyclonal antibody (Stressgen). (Lower Right) H 2 O 2 and OGD treatments that induce Nrf2-dependent gene expression in astrocytes are not toxic. Astrocytes were treated with the indicated concentrations of H 2 O 2 for 24 h or subjected to 3 h OGD followed by 21 h in normoxia and normal medium. Cellular viability was assessed using the CellTiter-Glo Luminescent Cell Viability Assay (Promega, Madison, WI) and also by assessing nuclear integrity of random fields of cells (>500 cells counted per treatment across three independent experiments; levels of nuclear pyknosis over and above control levels are shown). The CellTiter-Glo Luminescent Cell Viability Assay measures cellular ATP levels, and for each experiment, a standard curve of ATP concentrations was included to ensure that the levels of signal obtained from the cell samples were within the linear range of the assay. ) were subjected to 1.5 h of OGD, 24 h before a 3-h OGD exposure, after which they were returned to normal conditions for a further 21 h. Thereafter, cells were fixed, and death was assessed by blind counting of nuclear pyknosis (1,500-3,000 cells per treatment). *P < 0.01 (ANOVA followed by Tukey's posthoc test; n = 11 Nrf2
). Note that the 3-h OGD insult is not toxic to the astrocytes in the culture (Fig. 1) . Although preconditioning is observed in both Nrf2 +/+ and Nrf2 −/− cultures, the degree of protection is less in the Nrf2 −/− cultures. (Upper Right) The effect of preconditioning is lower in Nrf2 −/− cultures. The effect of preconditioning was calculated as the percentage of OGD-induced death that was prevented by the prior preconditioning episode. *P < 0.01 (Student t test; n = 11 Nrf2 +/+ ; n = 5 Nrf2 −/− ).
(Lower Left) Transient ischemia activates Nrf2 target genes in vivo. Srxn1 and Hmox1 expression was assessed 4 h after mice were subjected to a 15-min transient occlusion of the middle cerebral artery (MCAO), a stimulus known to elicit preconditioning in vivo. *P < 0.01 (paired t test; n = 6). The MCAO procedure was performed exactly as described (2), after which the mice were killed by terminal anesthesia and brains were snap-frozen in liquid nitrogen. RNA was then extracted from both ipsi-and contralateral cortical hemispheres and subjected to qPCR analysis of Srxn1 and Hmox1 expression, normalized to Gapdh levels. (Lower Right) Sub-toxic doses of H 2 O 2 induce Nrf2 target gene expression in human embryonic stem cell-derived astrocytes. Astrocytes were derived from the Hues9 human embryonic stem cell (hESC) line as described (5) . After 7 d of differentiation, hESC-derived astrocytes were treated with 50 μM H 2 O 2 , RNA was harvested 6 h later, and levels of SRXN1 and HMOX1 were analyzed by quantitative realtime-PCR (normalized to GAPDH levels). *P < 0.05 (n = 3).
